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Abstract
Background: IkappaB kinases (IKKs) regulate the activity of Rel/NF-kappaB transcription factors
by targeting their inhibitory partner proteins, IkappaBs, for degradation. The Drosophila genome
encodes two members of the IKK family. Whereas the first is a kinase essential for activation of
the NF-kappaB pathway, the latter does not act as IkappaB kinase. Instead, recent findings indicate
that Ik2 regulates F-actin assembly by mediating the function of nonapoptotic caspases via
degradation of DIAP1. Also, it has been suggested that ik2 regulates interactions between the minus
ends of the microtubules and the actin-rich cortex in the oocyte. Since spn-F mutants display oocyte
defects similar to those of ik2 mutant, we decided to investigate whether Spn-F could be a direct
regulatory target of Ik2.
Results: We found that Ik2 binds physically to Spn-F, biomolecular interaction analysis of Spn-F
and Ik2 demonstrating that both proteins bind directly and form a complex. We showed that Ik2
phosphorylates Spn-F and demonstrated that this phosphorylation does not lead to Spn-F
degradation. Ik2 is localized to the anterior ring of the oocyte and to punctate structures in the
nurse cells together with Spn-F protein, and both proteins are mutually required for their
localization.
Conclusion: We conclude that Ik2 and Spn-F form a complex, which regulates cytoskeleton
organization during Drosophila oogenesis and in which Spn-F is the direct regulatory target for Ik2.
Interestingly, Ik2 in this complex does not function as a typical IKK in that it does not direct SpnF
for degradation following phosphorylation.
Background
Protein kinases of the IκB kinase (IKK) family are known
for their roles in innate immune response signaling path-
ways in both mammals and Drosophila [1-3]. All mamma-
lian IKKs studied so far have roles in immune responses,
but operate on different targets. IKKs are multi-subunit
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IKKβ) and a structural component (IKKγ/NEMO). IKKα
and IKKβ were identified in a protein complex that phos-
phorylates IκB and targets it for degradation, thereby
allowing the nuclear localization and activation of NF-κB
transcription factors [4-6]. The isoforms IKKε and TANK
binding kinase 1 are required to for phosphrylation and
activation of the transcription factor interferon regulatory
factor 3 in response to viral infection [7-9]. Two members
of the IKK family are known in Drosophila, namely
DmIKKβ and Ik2 [10]. DmIKKβ performs similarly to the
mammalian IKKα and participates in antibacterial innate
immune response [11,12]. In contrast, ik2 (also known as
DmIKKε) was shown to control actin and microtubule
(MT) organization in an NF-κB-independent pathway
[10,13,14].
Recently it was reported that Ik2 binds to Drosophila inhib-
itor of apoptosis 1 (DIAP1) and accelerates its degrada-
tion in a kinase-dependent manner [13]. One of the
nonapoptotic processes that Ik2 regulates through the
DIAP1/caspase pathway is assembly of the actin cytoskel-
eton [14]. In ik2 loss-of-function mutants, tracheal termi-
nal cells, bristles, and the antenna arista laterals, all of
which require accurate F-actin assembly for their polar-
ized elongation, exhibited aberrantly branched morphol-
ogy. These phenotypes were sensitive to a change in the
dosage of DIAP1 and the caspase DRONC without appar-
ent change in cell viability [13]. In addition, over-expres-
sion of Ik2 destabilized F-actin based structures. These
results suggest that Ik2 may act as a negative regulator of
F-actin assembly, maintaining the fidelity of polarized
elongation during cell morphogenesis by modulating the
level of DIAP1.
A different aspect of the ik2 role in cytoskeleton related
processes is revealed through oogenesis studies. During
oogenesis, ik2 is required in an NF-κB-independent proc-
ess for localization of oskar and gurken mRNAs [10]. As a
result, females that lack ik2 in the germline produce
embryos that are bicaudal, ranging from headless
embryos to embryos with a duplicated abdomen in place
of the head and thorax. They also exhibit a ventralized
phenotype. Abnormal mRNA localization in ik2 mutant
oocytes could be attributed to defects in the organization
of MT minus-ends. In addition, ik2 mutant oocytes and
mutant escaper adults have abnormalities in the organiza-
tion of the actin cytoskeleton [10]. However, the regula-
tory target for ik2 in controlling the oocyte cytoskeleton is
still unknown.
In a global two-hybrid screen, Ik2 was found to interact
with Spindle-F (Spn-F) (CG12114) [15]. Our previous
work has shown that this newly discovered protein, Spn-F
is part of a yet uncharacterized pathway leading to the
organization of a distinct subset of MTs in the Drosophila
oocyte [16]. spn-F was first identified as a maternal effect
mutation that affects the dorsal-ventral polarity of the egg-
shell [17]. The asymmetric distribution of maternal deter-
minants (gurken, bicoid and oskar mRNAs) in the oocyte
was analyzed, and it was found that spn-F, like ik2, is
required for proper localization of gurken during oogene-
sis. In addition to the maternal effect, spn-F, like ik2, also
affects the bristle morphology of the adult fly. Moreover,
in spn-F mutants, α-tubulin is abnormally associated with
the oocyte nuclear periphery, and green fluorescent pro-
tein (GFP)-Tau fusion protein accumulates abnormally
around the oocyte nucleus. spn-F was cloned and found to
encode a novel coiled-coil protein, which co-localizes spe-
cifically to oocyte cortex regions, where the minus ends of
MTs reside, and also occurs in a punctate granular pattern
in the nurse cells [16]. Thus, earlier work show that spn-F
affects oocyte axis determination and the organization of
a subset of MTs during Drosophila oogenesis.
Since ik2 mutants share many phenotypes with spn-F,
including a very similar bristle phenotype, ventralized
eggshells, and specific effects on MT organization in oog-
enesis [10], we decided to study the nature of the interac-
tion between these two proteins. We show that Ik2
directly interacts with Spn-F and that the C-terminus of
Spn-F is crucial for this interaction. We also demonstrate
that Ik2 is capable of phosphorylating Spn-F, but that
such phosphorylation is not essential for their interaction
and also does not lead to Spn-F degradation. We find that
Ik2 and Spn-F co-localize to the anterior ring of the oocyte
and in a punctate structure in the nurse cells. Furthermore,
we show that Spn-F and Ik2 are mutually required for this
localization. We therefore conclude that Ik2 and Spn-F
form a complex that regulates cytoskeleton organization
during Drosophila oogenesis. Our finding that phosphor-
ylation of Spn-F by Ik2 has no effect on Spn-F protein deg-
radation, contrary to the degradation seen in the case of
DIAP1, demonstrates a new mode of action for Ik2 in the
germline.
Results
Spn-F interacts physically with Ik2
In a yeast two-hybrid-based protein-interaction map of
the fly proteome, several proteins were found to interact
with Spn-F, among them Ik2 kinase [15]. To further verify
the yeast two-hybrid interaction, we performed a co-
immunoprecipitation (co-IP) assay in Schneider (S2)
cells. Extracts from S2 cells co-expressing GFP-tagged Ik2
and hemagglutinin (HA)-tagged Spn-F were immunopre-
cipitated with antibodies against GFP and immunoblot-
ted with antibodies against HA. Our results demonstrated
that it is possible to co-precipitate Ik2 together with Spn-
F (Fig 1A), indicating that Spn-F interacts with Ik2, in
agreement with the findings of the yeast two-hybrid assay.Page 2 of 14
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Spn-F interacts physically with Ik2 and the C-terminus of Spn-F is crucial for this interactionFigure 1
Spn-F interacts physically with Ik2 and the C-terminus of Spn-F is crucial for this interaction. (A) Co-immunopre-
cipitation of GFP-Ik2 with HA-Spn-F. Proteins were extracted from S2 cells co-transfected with GFP-Ik2 and HA-Spn-F. 
Untreated lysate was run on gel (Total). The same lysate was incubated with α-GFP antibody and precipitated by protein A-
coated beads (IP-α-GFP), or was precipitated by protein A-coated beads without anti-GFP antibody (control). To detect Spn-F, 
western blotting was performed using α-HA antibodies. HA-Spn-F was successfully precipitated with GFP-Ik2. (B) Co-immuno-
precipitation of GFP-Ik2 with HA-Spn-F in the germline. Proteins were extracted from transgenic fly ovaries expressing either 
GFP-Ik2 with HA-Spn-F (right panel) or HA-Spn-F (control, left panel) in the germline. Ovarian extracts were incubated with 
α-GFP antibody and precipitated by protein A-coated beads (IP-α-GFP). To detect Spn-F western blotting was performed using 
α-HA antibodies. HA-Spn-F was successfully precipitated with GFP-Ik2. (C) Schematic diagram of Spn-F protein coil-coiled 
domains and truncated protein used in D. (D) Co-immunoprecipitation assay of myc-Ik2 with GFP-N'-Spn-F or GFP-C'-Spn-F. 
Proteins were extracted from S2 cells co-transfected with myc-Ik2 and GFP-N'-Spn-F or GFP-C'-Spn-F. Untreated lysate was 
run on gel (Total). The same lysate was incubated with α-GFP antibody and precipitated by protein A-coated beads (IP-α-GFP), 
or was precipitated by protein A-coated beads without anti-GFP antibody (control). To detect Ik2, western blotting was per-
formed using α-myc antibodies. Myc-Ik2 was co-precipitated with the C-terminus of Spn-F but not with the N-terminus of Spn-
F.
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interact physically in the germline. For that purpose we
expressed HA::Spn-F along GFP::Ik2 in the germline using
the UAS/Gal4 system. GFP::Ik2 was immunoprecipitated
from ovarian extract, and the presence of Spn-F was stud-
ied by western blot with antibodies against HA (Fig. 1B).
Similarly to our results in S2 cells, we were able to show
that Spn-F is found in a complex with Ik2 in the oocyte as
well (Fig, 1B, right panel).
The C-terminus of Spn-F is crucial for the interaction with 
Ik2
Spn-F protein is predicted to have two coiled-coil
domains http://smart.embl-heidelberg.de/. The first
domain extends from amino acid 32 to amino acid 114
and the second from amino acid 210 to amino acid 243
(Fig. 1C). In order to determine which domain is impor-
tant for the interaction with Ik2, we fused the N-terminal
part of Spn-F (1–162 aa) and the C-terminal (165–364
aa) of Spn-F to GFP. We co-expressed Myc-tagged Ik2 with
each of the GFP-tagged truncated proteins in S2 cells.
Extracts were immunoprecipitated with anti-GFP, and
immunoblotting was done using anti-Myc. Myc tagged
Ik2 was co-precipitated with the C-terminus of spn-F but
not with the N-terminus of Spn-F (Fig. 1D). These results
suggest that the C-terminus of Spn-F is crucial for the
interaction with Ik2.
Spn-F and Ik2 are co-localized in punctate structures in 
S2R+
Having established that Spn-F interacts physically with
Ik2 using co-IP in S2 cells, we decided to confirm the
localization pattern of these proteins in S2R+ cells. Expres-
sion of Cherry-tagged Spn-F revealed that the protein is
found in cytoplasmic punctate structures (Fig. 2A),
whereas expression of GFP-tagged Ik2 alone showed an
even distribution in the cell cytoplasm (Fig. 2B). The same
localization pattern for Ik2 was reported by [14]. When
we co-expressed GFP-Ik2 together with Cherry-Spn-F in
S2R+ cells, we found that Spn-F and Ik2 are co-localized to
the same cytoplasmic punctate structures (Fig 2E). These
results, together with our co-IP findings, indicate that co-
expression of both proteins is required for co-localization
to the same vesicles in S2R+ cells.
Biomolecular interaction analysis of Spn-F and Ik2 
complex
To test whether the interaction between Spn-F and Ik2
protein was direct and also to enable biomolecular inter-
action analysis of Spn-F with Ik2, we used the multichan-
nel ProteOn system (Bio-Rad). This method allowed us to
collect kinetic data for six different concentrations of ana-
lyte at the same time [18]. Fig. 3A shows representative
sensorgrams for binding of Spn-F in six concentrations to
Ik2. The results revealed dose-dependent formation of
this complex. In order to verify specific binding of Spn-F
to Ik2 as opposed to binding to maltose binding protein
(MBP), we examined the binding of Spn-F to a different
MBP-fused protein, namely Sec13-MBP (Fig. 3B). These
results show that there is no binding of Spn-F to Sec13-
MBP, indicating that the Spn-F binding to Ik2 is specific.
The data were globally fitted to the simple 1:1 interaction
model with χ2 of 1.63. The association and dissociation
rate constants are Ka = 4.15 × 103 M-1.s-1 and Kd = 1.69 ×
10-3 s-1, respectively. The KD equilibrium dissociation
constant, which is derived from KD = kd/ka, was found to
be 407.2 nM. Many examples of protein-protein interac-
tion with affinities in the nanomolar to molar range have
been described. For example, the KD value of complex for-
mation between EGF and EGF receptor is 410 nM [19].
Affinity values in the range of 0.5–500 nM were observed
in antibody/antigen complexes from hybridoma culture
supernatants [20]. KD of 4.67 μM was measured between
AMP-activated protein kinase (AMPK) and rat acetyl-CoA
carboxylase-1 (ACC1) [21]. The affinity between Spn-F
and Ik2 falls in the nanomolar range indicating a stable
complex formation resembling that of antibody-antigen
complexes.
Ik2 phosphorylates Spn-F
Since Ik2 is a serine/threonine kinase and binds to Spn-F
protein, we investigated whether Ik2 phosphorylates Spn-
F protein. S2 cells were co-transfected with Ik2 and Spn-F
or Spn-F alone. Extracts were subjected to SDS-polyacryla-
mide gel electrophoresis (SDS-PAGE), and Spn-F protein
migration on gel was analyzed by western blot with an
anti-Spn-F antibody. In cells co-expressing Spn-F and Ik2,
we found a reduction in the mobility of Spn-F protein (Fig
4A, lane 3) as compared with its migration when
expressed alone (Fig. 4A, lane 1). This reduced mobility of
Spn-F could be mitigated by treatment with calf intestinal
alkaline phosphatase (Fig 4A, lane 4), strongly suggesting
that Ik2 phosphorylates Spn-F. To confirm these results,
we performed an in vitro phosphorylation kinase assay.
GFP-tagged Ik2 was immunoprecipitated from S2 cells.
We studied the ability of this immunoprecipitate to phos-
phorylate purified His-tagged Spn-F protein. We found
that besides the autophosphorylation of GFP-Ik2 protein,
there was another 32P-labeled protein band at ~50 kD,
which corresponds to the mass of His-tagged Spn-F (Fig
4B, lane 2). Taken together with the shift in mobility, the
latter result demonstrates that Ik2 phosphorylates Spn-F.
The interaction between Spn-F and Ik2 does not depend 
on phosphorylation
It was recently shown that Ik2 phosphorylates and inter-
acts with DIAP1. The interaction between DIAP1 and Ik2
was not dependent on phosphorylation [13]. Accordingly
we proceeded to test the ability of Spn-F to interact with a
kinase dead form of Ik2, Ik2 K41A [14]. Western blot anal-Page 4 of 14
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with Ik2 K41A was similar to the migration of Spn-F when
expressed alone, proving that the kinase domain of Ik2 is
inactivated in the mutant (Fig 4C, lane 2). Although Spn-
F was not phosphorylated by Ik2 K41A, a specific interac-
tion between the proteins did take place (Fig 4D), indicat-
ing that the interaction between Ik2 and Spn-F proteins
does not depend on phosphorylation.
Ik2 does not promote Spn-F degradation
It was recently reported that Ik2 promotes degradation of
DIAP1 through direct phosphorylation [13]. Since Ik2
phosphorylates Spn-F in S2R+ cells, we examined whether
such phosphorylation of Spn-F leads to its degradation.
S2R+ cells were co-transfected with GFP-tagged Spn-F and
increasing amounts of GFP-tagged Ik2. Cell extracts were
subjected to western blot analysis with anti-GFP. We
found that while expression of different levels of GFP-Ik2
did lead to Spn-F phosphorylation, as revealed by the
change in Spn-F mobility, this phosphorylation did not
lead to its degradation (Fig. 5A). To determine whether
Ik2 influences the stability of Spn-F in flies, we tested the
stability of Spn-F in the germline while over-expressing
GFP::Ik2. For that purpose we generated transgenic flies
expressing GFP::Spn-F together with GFP::Ik2, then tested
the level of Spn-F protein relative to transgenic flies
expressing GFP::Spn-F or GFP alone. We demonstrated
that expression of Ik2 had no effect on Spn-F protein sta-
bility in the germline (Fig 5B), thus supporting our find-
ing that Ik2 does not promote Spn-F degradation.
Ik2 protein is co-localized with Spn-F in punctate form in 
the nurse cells and at the anterior ring of the oocyte
In order to examine the localization of Ik2, transgenic flies
expressing GFP-tagged Ik2 were generated. Expression of a
GFP-tagged UASp-ik2 transgene under the direction of the
ubiquitous actin-Gal4 driver rescued both the viability and
bristle abnormalities of ik2 allelic combinations com-
pletely (data not shown). It has been reported that over-
expression of Ik2 promotes DIAP1 elimination and
Spn-F and Ik2 are co-localized to distinct vesicles in S2R+Figure 2
Spn-F and Ik2 are co-localized to distinct vesicles in S2R+. Confocal images of (A) Cherry-tagged Spn-F (the protein is 
localized to distinct vesicles in the cell cytoplasm) and (B) GFP-tagged Ik2 (the protein is evenly distributed in the cell cyto-
plasm). (C-E), Co-transfection of Cherry-tagged Spn-F and GFP-tagged Ik2: (C) Cherry-tagged Spn-F, (D) GFP-tagged Ik2, (E) 
merged picture. GFP-tagged Ik2 localization has been altered and it is now co-localized to distinct cytoplasmic vesicles with the 
Cherry-tagged Spn-F protein.Page 5 of 14
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Biomolecular interaction analysis of Spn-F and Ik2 complexF gure 3
Biomolecular interaction analysis of Spn-F and Ik2 complex. Representative data set used for kinetic analysis of the 
interaction of Spn-F with Ik2-MBPHis. The figure depicts the concentration-dependent binding of Spn-F to1400 RU of captured 
Ik2MBPHis ligand. (A) Analyte protein injections at the indicated concentrations. (B) Graph illustrates lack of binding of Spn-F 
to a different MBP fused protein,. Sec13-MBP. This is a representative result from five different experiments.
BMC Cell Biology 2008, 9:51 http://www.biomedcentral.com/1471-2121/9/51induces cell death in somatic tissues [13]. However, we
found that flies over-expressing GFP-tagged Ik2 or UAS-
ik2 [10] in the germline are fertile and display no induc-
tion of apoptosis. We found that GFP-tagged Ik2 is local-
ized to the anterior end of the oocyte and is present in a
punctate pattern in the nurse cells, similarly to the pattern
found for Spn-F (Fig. 6A). Next, we decided to test
whether the GFP-tagged Ik2 co-localizes with endogenous
Spn-F protein. For that purpose, ovaries expressing GFP-
tagged Ik2 were immunostained with Spn-F antibody. We
observed that Spn-F and Ik2 were co-localized at the ante-
Ik2 phosphorylates Spn-F and the phosphorylation is not essential for physical interaction between the proteinsFigure 4
Ik2 phosphorylates Spn-F and the phosphorylation is not essential for physical interaction between the pro-
teins. (A) Western blot analysis for mobility shift assay. Lane 1 – S2 cells expressing Spn-F. Lane 2 – S2 cells expressing Spn-F 
that were treated with calf intestinal alkaline phosphatase (CIP). Lane 3 – S2 cells co-expressing Spn-F and Ik2. Lane 4 – S2 cells 
co-expressing Spn-F and Ik2 that were treated with CIP. Spn-F co-expressed with Ik2 migrates more slowly on the gel than 
Spn-F alone or after treatment with CIP. (B) In vitro kinase assay. Autophosphorylation of Ik2 and phosphorylated Spn-F is indi-
cated in lane 2. GFP or GFP-Ik2 was expressed in S2 cells and immunoprecipitated by anti-GFP. The immunoprecipitated pro-
teins were subjected to an in vitro kinase assay using recombinant HIS-Spn-F protein. (C) Western blot analysis for mobility 
shift assay. Lanes 1, 4 – S2 cells expressing GFP-Spn-F alone. Lane 2 – GFP-Spn-F and kinase dead Ik2 – IK2 [K41A]-Myc. Lane 
3 – GFP-Spn-F and Ik2. Kinase dead Ik2 does not affect the mobility of Spn-F whereas Ik2 retards its migration on the gel. (D) 
Co-immunoprecipitation of Ik2 [K41A]-Myc with HA-Spn-F. Proteins were extracted from S2 cells co-transfected with Ik2 
[K41A]-Myc and HA-Spn-F. Untreated lysate was run on gel (Total). The same lysate was incubated with α-myc antibody and 
precipitated by protein A-coated beads (IP-α-myc), or was precipitated by protein A-coated beads without anti-myc antibody 
(control). To detect Spn-F, Western blotting was performed using α-HA antibodies. HA-Spn-F was successfully precipitated 
with kinase dead Ik2.Page 7 of 14
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in the nurse cells (Fig. 6B–D).
IK2 and Spn-F are reciprocally required for localization to 
the anterior ring in the oocyte and to the punctate pattern 
in nurse cells
Having shown that Ik2 and Spn-F create a complex, we
tested whether the proteins are mutually required for their
correct localization. To determine whether Spn-F localiza-
tion depends on Ik2, we studied the localization of Spn-F
in ik2 mutants. Because ik2 mutants are lethal, we used
FRT/FLP recombination combined with the ovoD domi-
nant female-sterile mutation to generate mutant clones in
the female germline [22]. We observed that in ik2 germ-
line clones Spn-F aggregates in the oocyte during early
oogenesis and is no longer found in a tight posterior local-
ization as in the wild type (Fig. 7A, B). During mid-oogen-
esis Spn-F localization to the MT minus end is
significantly reduced in ik2 germline clones as compared
with wild-type egg chambers, and Spn-F aggregates in the
oocyte; there is also more punctate distribution of Spn-F
protein in the nurse cells (Fig 7D) as compared with the
wild type (Fig. 7C). We also analyzed GFP-Ik2 localization
in spn-F mutant ovaries and found that Ik2 localization to
the anterior ring of the oocyte was diminished (Fig. 7F).
These results show that the proteins are mutually depend-
ent for their correct localization.
Discussion
Recent studies implicate the Drosophila IKKε homologue
ik2 in seemingly unrelated NF-κB functions. It was shown
that ik2 modulates caspases for a nonapoptotic function
and controls both actin and MT cytoskeletons [10,13,14],
and also that it regulates the actin cytoskeleton through
phosphorylation and degradation of DIAP1 [14]. Moreo-
ver, it was reported that, in ik2 mutant oocytes, abnormal
mRNA localization can be attributed to defects in organi-
zation of MT minus-ends, giving rise to ventralized and
bicaudal phenotypes of mutant embryos [10]. Whereas
the control of actin polymerization appears to be medi-
ated by a nonapoptotic function of DIAP1, the regulatory
target of Ik2 in controlling cytoskeleton organization in
the oocyte is still unknown. In this study we examined
whether spn-F, which showed precisely the same ovarian
and bristle phenotypes as ik2 mutants, might be an Ik2
target. In previous work we reported that spn-F encodes a
novel protein that affects oocyte axis determination and
the organization of MTs during Drosophila oogenesis [16].
In this work we show that Ik2 physically interacts with
Spn-F and forms a relatively stable complex. In addition,
we show that Ik2 phosphorylates Spn-F but that the inter-
action between these two proteins is independent of
phosphorylation. Thus, our results suggest that Spn-F is a
putative regulatory substrate of Ik2. Moreover, our results
indicate that the nature of the interaction between Spn-F
and Ik2 is different from that attributed to Ik2 and DIAP1.
We showed that Spn-F phosphorylation by Ik2 had no
effect on its stability in S2 cells. Supporting this conclu-
sion is the finding that over-expression of Ik2 in the ova-
ries had no effect on Spn-F stability or development [10;
present study], indicating that over-expression of ik2 does
not lead to Spn-F degradation. Furthermore, the ovarian
phenotype of spn-F mutant is similar to the ovarian phe-
notype of ik2 [10,16]. Thus, whereas Ik2 regulates organi-
zation of the actin cytoskeleton via phosphorylation and
degradation of DIAP1, in the oocyte, rather than affecting
Spn-F degradation, Ik2 and Spn-F form a complex that
regulates the oocyte cytoskeleton.
How does the IK2/Spn-F complex function in the germ-
line? In this study, we showed that Ik2 and Spn-F are co-
localized both to the anterior ring during mid-oogenesis
and to punctate structures in the nurse cells. Additionally,
Ik2 and Spn-F are mutually required for correct localiza-
tion in the germline. In ik2 germline clones, Spn-F protein
localization along the anterior cortex is significantly
reduced relative to the wild-type egg chamber and Spn-F
aggregates in the oocyte; also, there is a higher accumula-
tion of the punctate structures containing Spn-F protein in
the nurse cells as compared with the wild type. Further-
more, we found that Ik2 localization to the anterior end
of the oocyte and to the punctate structure in the nurse
cells depends on spn-F. Thus, we suggest that the correct
localization of Spn-F and Ik2 complex to special compart-
ment within the oocyte is an essential requirement for
organization of oocyte cytoskeleton. The defects observed
in ik2 and spn-F mutants oocyte are most likely due to
misslocalization of the Ik2/Spn-F complex.
Immunostaining has shown that Spn-F protein localizes
to the minus end of the MT network in the oocyte and also
to granules in the nurse cells. In our previous work we
found that depolymerization of MT and mutations in
Dynein heavy chain cause a significant loss of Spn-F locali-
zation at the oocyte anterior cortex [16]. In addition, these
treatments results in substantial increase in both the
number and the size of Spn-F granules in the nurse cells.
These observations suggest that Spn-F is transported from
the nurse cells to the oocyte and that this transport could
be mediated by Dynein. In the present study we found
that when Ik2 was expressed alone in S2R+ cells, it was
evenly distributed in the cytoplasm whereas Spn-F local-
ized to cytoplasmic punctate structures. When both pro-
teins were co-expressed in S2R+, Ik2 was co-localized to
the cytoplasmic punctate structures along with Spn-F.
Moreover, we found a higher accumulation of punctate
structures containing Spn-F protein in the nurse cells in
ik2 mutants as compared with the wild type, similarly to
our observation in Dynein heavy chain mutant. Taking all
of our results into account, we would like to propose thatPage 8 of 14
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Ik2 does not promote Spn-F degradationFigur  5
Ik2 does not promote Spn-F degradation. (A) Western blot analysis for Spn-F protein levels. S2 cells were co-transfected 
with GFP-Spn-F and increasing amounts of GFP-Ik2 (0, 200, 500,1000 ng). Ik2 did not affect Spn-F protein levels. (B) Western 
blot analysis for Spn-F protein stability in the germline. The level of Spn-F in the germline was examined in the presence of 
over-expression of Ik2. Ovarian extracts from flies expressing GFP::Spn-F and GFP::Ik2 was tested in comparison with ovarian 
extracts from transgenic flies expressing GFP::Spn-F or GFP. Our results showed that expression of Ik2 does not affect Spn-F 
stability in the germline.
BMC Cell Biology 2008, 9:51 http://www.biomedcentral.com/1471-2121/9/51Spn-F is required for localization of Ik2 to cytoplasmic
transport vesicles while Ik2 is required for correct trans-
port of the complex from nurse cells to oocyte. Once the
complexes are in the oocyte, they may accumulate at cer-
tain cortical sites where they promote the interaction of
MTs and the actin cytoskeleton.
Conclusion
In conclusion, we have demonstrated that Ik2 and Spn-F
form a complex which regulates cytoskeleton organiza-
tion during Drosophila oogenesis and in which Spn-F is the
direct regulatory target for Ik2. Unlike other IKK proteins,




Oregon-R and Canton-S were used as a wild-type control.
The following mutant and transgenic flies were used: spn-
F1, spn-F2, pUASp HA tagged spn-F [16], ik21 [10]. Germ-
line expression was performed with nanos-Gal4-VP16 [23]
and ubiquitous expression with Act5C-GAL4 (Blooming-
ton). Germline clones for ik2 were generated using the
ovoD-FLP technique and FRT40A (2L) [22]. To induce
expression of FLP recombinase, flies were mated for 24
hours, and second instar larvae were heat shocked in a
37°C water bath for two hours on three consecutive days.
Constructs and transgenic flies
The entire coding sequence of enhanced green fluorescent
protein (EGFP) (Invitrogen) was amplified by PCR using
modified primers to create a KpnI restriction site at the 5'
end (EGFP-KPN-F-5' GGTACCATGGTGAGCAAG-
GGCGAGGAGC 3') and an XbaI site at the 3' end (EGFP
Xba R – 5' TCTAGACTTGTACAGCTCGTCCATGCCG 3').
The resulting PCR product was digested using KpnI and
XbaI and was cloned into pBlueScript to create the EGFP
pBlueScript vector. This vector was later used to clone all
Ik2 protein is co-localized with spn-F in the nurse cells and at the anterior ring of the oocyteFigu e 6
Ik2 protein is co-localized with spn-F in the nurse cells and at the anterior ring of the oocyte. (A) Live imaging of 
stage 9 egg chamber from nanos-Gal4; pUASP GFP-Ik2 transgenic flies. Ik2 is localized to the anterior end of the oocyte. (B-D) 
Confocal image of stage 8 egg chamber from nanos-Gal4; pUASP GFP-Ik2 transgenic flies stained with anti-Spn-F. (B) GFP-Ik2 
in green; (C) immunostaining for Spn-F in red; (D) merged picture. Both proteins are co-localized along the anterior cortex of 
the oocyte and in a punctate pattern in the nurse cells. Egg chambers are positioned that the anterior (A) is to the left left and 
posterior end (P) is to the right.Page 10 of 14
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BMC Cell Biology 2008, 9:51 http://www.biomedcentral.com/1471-2121/9/51of the pUASp GFP-tagged constructs. The full length spn-F
coding sequence was amplified by PCR from EST
(LD01470) using modified primers to create an XbaI
restriction site at the 5' end (5' TCTAGAATGGAG-
GCATCTGCTGCCAAAATC 3') and an NotI site at the 3'
end (5' GCGGCCGCCTGGGTCAGAAGTCACC 3'). To
create the N-truncated GFP-tagged form of spn-F, the cod-
ing sequence from 1–486 bp was amplified by PCR using
modified primers to create an XbaI restriction site at the 5'
end (5' TCTAGAATGGAGGCATCTGCTGCCAAAATC 3')
and an NotI restriction site at the 3' end (5' GCGGCCGCT-
CATTGGCATCTGGTTCACT 3'). To create the C-truncated
Ik2 and Spn-F are mutually dependent for their correct localizationFigure 7
Ik2 and Spn-F are mutually dependent for their correct localization. (A-D) Confocal images of wild-type egg cham-
bers (A, C) or ik2 germline clone egg chambers (B, D); red indicates Spn-F. In ik2 germ line clones during early oogenesis (B), 
Spn-F is no longer found in a tight posterior localization as in the wild type (A). During mid-oogenesis (D) in ik2 germ line 
clones, Spn-F localization along the anterior cortex is significantly reduced compared with the wild-type egg chamber (C) and 
Spn-F aggregates in the oocyte; also, there is a more punctate distribution of Spn-F protein in the nurse cells compared with 
the wild type (C). (E, F), Live imaging of stage 8 egg chamber from nanos-Gal4; pUASP GFP-Ik2 transgenic flies (E) or nanos-
Gal4; pUASP GFP-Ik2 in spn-F mutant background (F). In spn-F mutant ovaries, Ik2 localization to the anterior ring of the 
oocyte is diminished and there is a reduction in the punctate form in the nurse cells.Page 11 of 14
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BMC Cell Biology 2008, 9:51 http://www.biomedcentral.com/1471-2121/9/51GFP-tagged form of spn-F, the coding sequence from 495–
1095 bp was amplified by PCR using modified primers to
create an XbaI restriction site at the 5' end (5' TCTA-
GAACGCAGCACTCCCCCAATCCTCACC 3') and an NotI
restriction site at the 3' end (5' GCGGCCGCCTGGGTCA-
GAAGTCACC 3'). To create a full length GFP-tagged form
of Ik2, the entire coding sequence of Ik2 was amplified by
PCR from EST (SD10041) using modified primers to cre-
ate an XbaI restriction site at the 5' end (5' TCTAGAAT-
GTCCTTCCTGCGCGGTTCCGTAAGC 3') and an NotI site
at the 3' end (5' GCGGCCGCCTAACTACTTTCCAGACT-
TCCG 3'). All of the above PCR products were digested
using XbaI and NotI and were cloned into EGFP-pBlue-
Script. The resulting pBlueScript vectors were cut using
KpnI and NotI and the inserts cloned into pUASp vectors.
To create an mCherry-tagged Spn-F, mCherry in pCS2 was
amplified by PCR, using modified primers to create KpnI
restriction sites at both ends (5' CGGGGTACC ATGGT-
GAGCAAGGGCGAGG 3' and 5' CGGGGTACC CTTGTA-
CAGCTCGTCCATGCCGC 3'). The resulting PCR product
was digested with KpnI and then inserted into a pUASp
vector containing Spn-F coding sequence from EST (LD-
01470). P-element-mediated germline transformation of
this construct was carried out according to standard pro-
tocols [24]. Ten independent lines were established from
each construct.
Antibody Staining
Ovaries were dissected in PBS, then fixed for 20 minutes
(3.8% formaldehyde in PBS and Heptane) and washed 3
× 10-min in PBST (PBS, 0.3% Triton X-100). The ovaries
were incubated for 1 h in PBS, 1% Triton X-100, and
blocked for 1 hr in 3% BSA, PBST. After overnight incuba-
tion at 4°C with primary antibody in appropriate dilution
and PBST washes, the ovaries were incubated with second-
ary antibody for 1 h, washed, and mounted in 50% glyc-
erol. As a primary antibody we used monoclonal mouse
anti-Spn-F (1:10; clones 8C10, 4E6 and 10C5). The sec-
ondary antibody, Cy3 goat α-mouse, was used at 1:100
(Jackson Immunoresearch). Egg chambers were imaged
on a Zeiss LSM510 laser-scanning confocal microscope.
Egg chamber live imaging
Female flies were mated and fed dry yeast for at least 3
days after eclosion. Ovaries and egg chambers were dis-
sected in a Halocarbon oil 700 (Sigma) drop placed on a
24 × 66 mm cover glass. Confocal images were taken
within 40 min after the dissection on an Olympus FV1000
laser-scanning confocal microscope.
Cell culture and transfections
S2 or S2R+ cells were cultured in Schneider's cells Dro-
sophila medium (Biolabs Industries, Israel) containing
10% fetal bovine serum (Biolabs industries, Israel) and
penicillin (10,000 u/ml)-streptomycin (10 mg/ml)-
amphotericin B (0.025 mg/ml) solution (1:100, Biolabs
Industries, Israel). Cells were maintained at 25°C under
normal atmosphere. 4*106 cells were transfected with 1
μg pUASp-based expression vectors and the Act5C-Gal4
driver by using Escort IV (Sigma). The transfected cells
were cultured in Schneider's cells Drosophila medium
without Bovine serum and antibiotics for 24 h. For west-
ern blot analysis the cells were treated in SDS sample
buffer. For co-localization assay cells were fixed for 15
min (3.8% formalin in PBS), then washed 3 × 10 min in
PBS and mounted in 50% glycerol. Cells were imaged on
confocal microscope.
Western blot analysis
Proteins were loaded onto a 10% polyacrylamide gel. Fol-
lowing electrophoresis, proteins were transferred to nitro-
cellulose membranes (PROTRAN, Schleicher & Schuell)
for 1 h at 300 mA. The nitrocellulose membranes were
blocked by incubation in TTBS (0.2 M Tris, 1.5 M NaCl, 9
mM Tween 20) containing 5% nonfat dry milk, for 30
min at room temperature followed by 1 h incubation in
primary antibody. The membranes were washed in TTBS
and incubated for 30 min with either a horseradish perox-
idase (HRP)-labelled anti-rabbit or anti-mouse antibodies
(Amersham) at a 1:2000 dilution each. The signals were
visualized using ECL detection kit (biological industries).
Primary antibodies used were: anti-HA (1:500, Santa Cruz
Biotechnology), polyclonal anti Spn-F (1:1000), anti-GFP
(1:1000, Roche diagnostic), anti-Myc (1:1000, Santa Cruz
Biotechnology), anti α-tubulin (1:1000, Sigma). For
phosphatase treatment, cell extracts were incubated with
calf intestinal phosphatase (10 units, New England
Biolabs) at 37°C for 15 min. The reaction was stopped by
the addition of sample buffer.
Co-immunoprecipitation assay
Ovaries from GFP-Ik2; HA-Spn-F/nanos- Gal4 or HA-Spn-
F/nanos Gal4 expressing flies were dissected in PBS. Lysates
were prepared by grinding 10 ovaries for 15 sec in 50 μl
cold lysis; PB, 1% NP-40 and protease inhibitors (Sigma).
The lysate was spun for 5 min in a microcentrifuge at max-
imum speed, and 5 μl of the supernatant was set aside for
use as a whole cell lysate control. The remaining lysate
was pre-cleared with protein A coated beads (Adar Bio-
tech). After a 30 min incubation on ice, the pre-cleared
lysates were incubated with anti-GFP (1:250, Roch Diag-
nostic) and protein A coated beads. After incubation,
beads were washed in lysis buffer, resuspended in an
equal volume of protein gel loading buffer, and loaded
onto 10% polyacrylamide gel. To detect interaction
between proteins, western blot with anti-HA antibody was
performed.
Cells expressing constructs as described in the text were
treated with lysis buffer (PBS, 1%Triton X-100 and pro-Page 12 of 14
(page number not for citation purposes)
BMC Cell Biology 2008, 9:51 http://www.biomedcentral.com/1471-2121/9/51tease inhibitors). Pre-cleared extracts were incubated over-
night at 4°C with anti-myc (1:250, Santa Cruz) or anti-
GFP (1:250, Roche Diagnostic) mouse monoclonal anti-
bodies. Immunocomplexes were recovered by incubation
with protein A coated beads (Adar Biotech) for 2 h at 4°C.
To detect interaction between proteins, western blot with
α-HA antibody or α-myc antibody was performed. As a
negative control, the ovarian lysate was precipitated by
protein A-coated beads without antibody.
Immunocomplex Kinase Assay
Cells were treated with lysis buffer containing 20 mM Tris-
HCl pH 7.5, 12 mM β-glycerophosphate, 150 mM NaCl,
5 mM EGTA, 10 mM NaF, 1% Triton X-100, 1 mM DTT, 1
mM sodium orthovanadate, 1 mM PMSF, and 1.5% apro-
tinin. The cell extracts were clarified by centrifugation, and
the supernatants were immunoprecipitated with anti-
GFP. The immunocomplexes were incubated with [γ-32P]
ATP and purified His-tagged Spn-F recombinant protein
[16] that was used as a substrate. The kinase assay was
done in a final volume of 20 μl of a solution containing
20 mM Tris-HCl pH 7.5, 20 mM MgCl2, and 100 μM ATP.
The kinase reactions were stopped by adding SDS sample
buffer and analyzed by SDS-PAGE. The gel was exposed to
X-ray film for 24 h and visualized by a Fuji LAS3000 image
analyzer.
Protein stability assay in S2R+
For studying the effect of increasing levels of Ik2 on Spn-F
stability, S2R+ cells were transfected with different concen-
trations of pUASp-GFP-Ik2 vector (0, 200, 500, 1000 ng)
and pUASp-GFP-Spn-F (1000 ng). The expressions of the
proteins were driven by Actin-GAL4 (1000 ng). Empty
pUASp vector was added to adjust the total amount of
expression plasmid to 3000 ng/well. Cell extracts were
subjected to western blot analysis with anti-GFP antibody.
Protein Expression and Purification
The open reading frame encoding Spn-F from EST
(LD01470 was amplified by PCR using modified primers
to create an EcoRI restriction site at the 5' end (5' CGAAT-
TCATGGAGGCATCTGCCTG 3') and HindIII restriction
site at the 3' end (5' CGTCAAGCTTTCAGAAGTCACCCAC
3'). The open reading frame encoding Ik2 from EST
(SD10041) was amplified by PCR using modified primers
to create a BamHI restriction site at the 5' end (5'
CGGATCCCATGTCCTTCCTGCGCGG 3') and an SalI
restriction site at the 3' end(5' GCCGTCGACCTAAC-
TACTTTCCAGACTTC 3'). The PCR products were digested
with the appropriate restriction enzymes and cloned into
pMBPHis-Parallel1 [25] vector, containing N terminal
MBP-His6 tags followed by a TEV proteolysis site. The
plasmids coding for the fusion proteins were overex-
pressed in BL21 DE3 Escherichia coli cell, grown in 2.4l
2xYT media (containing 200 mg ampicillin). The culture
was grown at 37°C to an approximate A600 O.D. of 0.4–
0.6. Protein expression was induced by addition of 0.4
mM IPTG (Bio-Labs, USA), and the culture was further
incubated for 2 h at 37°C. Cells were harvested at 4°C by
centrifugation at 12,000 rpm. The cell pellets were resus-
pended in lysis buffer (Tris-HCl 20 mM pH 8, NaCl 200
mM, EDTA 1 mM, β-mercaptoethanol 5 MM, sudium
azide 0.02%) containing protease inhibitors PMSF (1
mM) and E64 (10 μM) (Sigma, USA). Cells were lysed by
sonication (Sonics & Materials, USA). The cell lysates were
centrifuged at 12,000 rpm for 25 min. at 4°C. The super-
natant solution was loaded onto an Amylose High Flow
(New England bio-labs, England) column pre-equili-
brated with loading buffer (Tris-HCl 20 mM pH 8, NaCl
200 mM, EDTA 1 mM, β-mercaptoethanol 5 mM,. The
protein was eluted with the same buffer with the addition
of 10 mM maltose. The fusion protein Ik2-MBPHis was
dialysed against loading buffer containing NaCl 50 mM
and eluted from an ion exchange HiTrap ANX FF column
(Amersham, SwedenS) in a salt gradient of 0.05–1 M
NaCl. Ik2-MBPHis was obtained in the unbound fraction.
Spn-F fusion protein was further cleaved with TEV
(tobacco etch virus) protease in cleavage buffer (Tris-HCl
0.5 M pH 8, EDTA 5 mM, DDT 1 mM) at 4°C overnight.
The cleaved Spn-F was dialysed against loading buffer
(Tris-HCl 20 mM pH 8, NaCl 200 mM, β-mercaptoetha-
nol 5 mM, sodium azide 0.002%), and loaded onto a
nickel HiTrap IMAC FF column (GEHealthcare, USA). The
unbound Spn-F was dialysed against loading buffer con-
taining NaCl 50 mM and eluted from an ion exchange
HiTrap ANX FF column (Amersham, Sweden) in a salt gra-
dient of 0.05–1 M NaCl. To verify the complete removal
of MBPHis tag from Spn-F sample, western analysis with
an anti-His antibody was performed; no signal was
detected. Furthermore, MALDI-TOF analysis confirmed
that the sample contained only pure Spn-F. Finally, the
proteins Spn-F and Ik2-MBPHis were dialysed against
buffer PBS.
Binding measurements
Binding affinities of Spn-F toward Ik2 were measured
using the ProteOn XPR36 Protein Interaction Array sys-
tem (Bio-Rad, USA) based on surface plasmon resonance
(SPR) technology [18,26]. As negative control we used
Sec13-MBP protein (Dictybase ID-DDB0235182). A solu-
tion of 0.005% Tween 20 in PBS, pH 7.4, was used as run-
ning buffer at a flow rate of 30 μl/min, at 25°C. Three
channels (GLC sensor chip) were activated for 5 min with
a mixture of 0.2 M EDC (1-ethyl-3-(3-dimethylaminopro-
pyl)carbodimide hydrochloride) and 0.05 M sulfo-NHS
(solfo-N-hydroxysuccinimide). Immediately after activa-
tion of the surfaces, Ik2-MBPHis (1 μg in 10 mM sodium
acetate, pH 5.5) and Sec13-MBP (1 μg in 10 mM sodium
acetate, pH 4.5) were injected across channel 2 and 3,
respectively. This resulted in Ik2-MBPHis coupled atPage 13 of 14
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response levels of 5500 RU. Channel 1 served as reference.
Finally, all 3 channels were blocked with 1 M eth-
anolamine-HCl (pH 8.5). Spn-F was then injected perpen-
dicular to ligands, at six different concentrations, using a
twofold dilution series within a range of 0.1625 to 5 μM.
The six concentrations were injected simultaneously at a
flow rate of 65 ul/min for 2.5 min of association phase
followed by 10 min of dissociation phase at 25°C. The
GLC sensor chip was regenerated with short injection of
50 mM NaOH between consecutive measurements.
Results are expressed in arbitrary resonance units (RU)
with subtraction of RU values from channel 1. Data were
analyzed with ProteOn managerTM software, using the
Langmuir model (A + B ↔ AB) for fitting kinetic data [23].
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